Who owns STOK?
Institutional ownership of Stoke Therapeutics Inc. from Form 13F, Q2 2026
198 institutional managers reported holding Stoke Therapeutics Inc. (STOK) in Form 13F filings for Q2 2026, with 77,376,476 shares worth $2.5B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 6,055,432 shares (+8.7%). 28 opened new positions and 29 sold out.
- Funds holding
- 198
- Value held
- $2.5B
- New / sold out
- 28 / 29
- Net shares, same filers
- +8.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of STOK
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $192M | 7.6% | 5,877,357 | Added |
| RTW Investments, LP | $184M | 7.3% | 5,623,525 | Unchanged |
| FMR LLC | $174M | 6.9% | 5,313,100 | Trimmed |
| Lynx1 Capital Management LP | $132M | 5.2% | 4,038,404 | Trimmed |
| Redmile Group, LLC | $129M | 5.1% | 3,945,920 | Trimmed |
| Wellington Management Group LLP | $115M | 4.5% | 3,519,301 | Added |
| Morgan Stanley | $113M | 4.5% | 3,452,795 | Added |
| Baker Bros. Advisors LP | $109M | 4.3% | 3,336,697 | Unchanged |
| Toronto Dominion Bank | $104M | 4.1% | 3,173,258 | Unchanged |
| State Street Corp | $93.3M | 3.7% | 2,852,240 | Added |
| Price T Rowe Associates Inc | $87.1M | 3.4% | 2,661,739 | Added |
| Vanguard Capital Management LLC | $84.6M | 3.3% | 2,586,937 | Added |
| BVF Inc | $83.4M | 3.3% | 2,547,557 | Unchanged |
| T. Rowe Price Investment Management, Inc. | $79.0M | 3.1% | 2,415,139 | Added |
| Assenagon Asset Management S.A. | $73.8M | 2.9% | 2,256,776 | Added |
| Siren, L.L.C. | $65.3M | 2.6% | 1,995,347 | Unchanged |
| Deerfield Management Company, L.p. | $59.7M | 2.4% | 1,823,500 | Unchanged |
| Jupiter Topco LLC | $59.4M | 2.3% | 1,814,408 | First report |
| Geode Capital Management, LLC | $49.9M | 2.0% | 1,524,309 | Added |
| Dimensional Fund Advisors LP | $33.2M | 1.3% | 1,013,911 | Added |
| Polar Capital Holdings Plc | $27.3M | 1.1% | 833,716 | Trimmed |
| EcoR1 Capital, LLC | $24.0M | 0.9% | 735,000 | Added |
| MPM Bioimpact LLC | $23.7M | 0.9% | 723,314 | Trimmed |
| Opaleye Management Inc. | $22.9M | 0.9% | 700,000 | Unchanged |
| Goldman Sachs Group Inc | $18.8M | 0.7% | 575,344 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 77,376,476 STOK shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- T. Rowe Price Investment Management, Inc. Added+$70.8M
- Assenagon Asset Management S.A. Added+$44.2M
- Price T Rowe Associates Inc Added+$23.8M
- EcoR1 Capital, LLC Added+$20.8M
- State Street Corp Added+$18.8M
- BlackRock, Inc. Added+$16.1M
- Wellington Management Group LLP Added+$13.9M
- Citadel Advisors LLC Added+$12.0M
- First Trust Advisors LP Added+$10.7M
- Jane Street Group, LLC Added+$8.7M
Biggest sellers in Q2 2026
- Lynx1 Capital Management LP Trimmed-$23.7M
- Polar Capital Holdings Plc Trimmed-$9.8M
- Bank of America Corp Trimmed-$9.3M
- Goldman Sachs Group Inc Trimmed-$8.4M
- Redmile Group, LLC Trimmed-$7.1M
- Millennium Management LLC Trimmed-$6.9M
- Tang Capital Management LLC Trimmed-$6.5M
- Troluce Capital Advisors LLC Trimmed-$5.1M
- Susquehanna Portfolio Strategies, LLC Trimmed-$3.6M
- Invesco Ltd. Trimmed-$2.7M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $316M and sold $118M; 75 added and 57 trimmed.
Schedule 13D and 13G filings on STOK
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-09-30BIOTECHNOLOGY VALUE FUND L P SCHEDULE 13G filed by Stoke Therapeutics Inc.Schedule 13G
- 2026-05-15WELLINGTON MANAGEMENT GROUP LLP SCHEDULE 13G filed by Stoke Therapeutics Inc.Schedule 13G
- 2025-11-14TORONTO DOMINION BANK SCHEDULE 13G filed by Stoke Therapeutics Inc.Schedule 13G
- 2025-06-06FMR LLC SCHEDULE 13G filed by Stoke Therapeutics Inc.Schedule 13G
Questions about STOK ownership
- Who owns STOK stock?
- 198 institutional investment managers reported STOK positions in their Form 13F filings for Q2 2026, holding 77,376,476 shares worth $2.5B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling STOK?
- In Q2 2026, 28 managers opened new STOK positions, 75 added, 57 trimmed and 29 sold out. Managers that filed in both quarters added a net 6,055,432 shares.
- How current is this STOK institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to STOK by CUSIP. Options are left out. STOK news and filings · STOK insider trades · Top funds